Does FENOFIBRATE Cause Interstitial lung disease? 39 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 39 reports of Interstitial lung disease have been filed in association with FENOFIBRATE (Fenofibrate). This represents 0.7% of all adverse event reports for FENOFIBRATE.
39
Reports of Interstitial lung disease with FENOFIBRATE
0.7%
of all FENOFIBRATE reports
2
Deaths
17
Hospitalizations
How Dangerous Is Interstitial lung disease From FENOFIBRATE?
Of the 39 reports, 2 (5.1%) resulted in death, 17 (43.6%) required hospitalization, and 13 (33.3%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
Yes, Interstitial lung disease is listed as a known adverse reaction in the official FDA drug label for FENOFIBRATE.
What Other Side Effects Does FENOFIBRATE Cause?
Myalgia (411)
Dyspnoea (373)
Fatigue (365)
Asthenia (356)
Dizziness (356)
Fall (354)
Drug ineffective (326)
Pruritus (325)
Nausea (311)
Diarrhoea (310)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which FENOFIBRATE Alternatives Have Lower Interstitial lung disease Risk?
FENOFIBRATE vs FENOFIBRIC ACID
FENOFIBRATE vs FENOTEROL
FENOFIBRATE vs FENOTEROL HYDROBROMIDE
FENOFIBRATE vs FENOTEROL HYDROBROMIDE\IPRATROPIUM
FENOFIBRATE vs FENTANYL